Health

Lupin launches antiviral drug Favipiravir under the name Covihalt to treat mild to moderate COVID-19 infection

Lupin launches antiviral drug Favipiravir under the name Covihalt to treat mild to moderate COVID-19 infection
Written by admin
Lupin launches antiviral drug Favipiravir under the name Covihalt to treat mild to moderate COVID-19 infection

Lupin launches antiviral drug Favipiravir below the identify Covihalt to deal with gentle to reasonable COVID-19 an infection

49883123476 196366501d k 1

The Covihalt pill will probably be obtainable in 200 mg tablets in a strip of 10 and can price Rs 49 per pill in India.

Drug main Lupin on Wednesday introduced the launch of its Favipiravir drug below the model identify ‘Covihalt’ for the remedy sufferers with gentle to reasonable COVID-19 signs at Rs 49 per pill in India.

Favipiravir has obtained authorisation from the Drug Controller Basic of India (DCGI) for emergency use, Lupin mentioned in a regulatory submitting.

Its Covihalt dosage energy has been developed conserving in thoughts comfort of administration, it acknowledged, including that the drug is accessible as 200 mg tablets within the type of a strip of 10 tablets, and priced at Rs 49 per pill.

Lupin President – India Area Formulations (IRF) Rajeev Sibal mentioned the corporate believes that it may well leverage its experience in managing widespread neighborhood ailments like tuberculosis to proactively attain sufferers throughout India and guarantee entry to Covihalt by its sturdy distribution community and discipline drive.

On four August, Solar Pharmaceutical Industries had launched Favipiravir below the model identify ‘FluGuard’ for the remedy of gentle to reasonable circumstances of COVID-19, at Rs 35 per pill in India.

Shares of Lupin had been buying and selling 0.32 per cent increased at Rs 943.70 apiece on BSE.

#Lupin #launches #antiviral #drug #Favipiravir #Covihalt #deal with #gentle #reasonable #COVID19 #an infection

About the author

admin